National Cancer Institute Research - Small Business Innovation Research and Small Business Technology Transfer
Active
- Assistance listing
- 93.CA6
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0849-0-1-550
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health National Cancer Institute funds Small Business Innovation Research and Small Business Technology Transfer grants under CFDA 93.CA6 to support domestic small business engagement in cancer research and development with commercialization potential. The source provides no recent grant award dates, open opportunities, or portfolio activity data; program recency and current funding cadence cannot be determined from the available information.
The program funds two distinct tracks: SBIR grants to small businesses conducting cancer research independently, and STTR grants to small businesses partnering with U.S. research institutions on cooperative cancer research and development. Both require research performance in the United States or its possessions. SBIR applicants must be independently owned and operated entities with no more than 500 employees and no dominant market position in the proposed research field; the principal investigator must have primary employment (more than half-time) with the small business at award and throughout the project. STTR applicants must be small businesses partnering with a research institution where the small business performs at least 40 percent of the project and the institution performs at least 30 percent; STTR principal investigators need not be primarily employed by the small business.
Evaluation criteria for Phase I applications include soundness and technical merit of the proposed approach, qualifications of the principal investigator and supporting staff, technological innovation, commercial application potential, budget appropriateness, and facility adequacy. Phase II applications are additionally assessed on the degree to which Phase I objectives were met and feasibility was demonstrated, as well as the technological innovation and societal importance of the proposed research.
All applications undergo competitive scientific peer review by an appropriate scientific review panel and, if recommended for further consideration, by a national advisory council or board. Applications compete for available SBIR and STTR set-aside funds on the basis of scientific and technical merit, commercial potential, program relevance, and program balance among research areas. Applicants may appeal substantive or procedural aspects of the review process through NIH Peer Review Appeal procedures.
Objective and description
- Objective
The overarching objective is to support Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs by engaging domestic small business concerns in federal cancer research and development that has the potential f
- Description
To support Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs by engaging domestic small business concerns in federal cancer research and development that has the potential for commercialization.
Eligibility
- Applicant eligibility
SBIR Grants: SBIR grants can be awarded only to domestic small business concerns-entities that are independently owned and operated for profit, are not dominant in the field of the proposed research, and have no more than 500 employees. The principal investigator (PI) must have primary employment (more than half-time) with the small business at the time of the award and for the duration of the project. For both Phase I and Phase II, the research must be performed in the United States or its possessions. Applications are eligible for funding only if they are approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR Grants: STTR grants can be awarded only to domestic small business concerns that partner with a U.S. research institution for cooperative research and development. The small business must perform at least 40% of the project, and the research institution must perform at least 30%. The research must be conducted in the United States or its possessions. Unlike SBIR, the PI does not need to be primarily employed by the small business. Applications must be approved for scientific merit and program relevance by a scientific review group and a national advisory council to be eligible for funding.
How to apply
- Criteria for selecting proposals
The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; and (8) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.
- Award procedure
All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and if they are recommended for further consideration, by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
- Renewals
Applications submitted for renewal are reviewed and selected for funding on a competitive basis.
- Appeals
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH homepage https://grants.nih.gov/grants/guide/notice-files/not-od-11-064.html.
Quick answers
What is Assistance Listing 93.CA6?
Assistance Listing 93.CA6 is National Cancer Institute Research - Small Business Innovation Research and Small Business Technology Transfer, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for National Cancer Institute Research - Small Business Innovation Research and Small Business Technology Transfer?
Its CFDA number is 93.CA6: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program